Abstract
Introduction
This article concisely overviews the complex relationship between obesity and bone health. Obesity, characterized by excessive fat accumulation, has been traditionally associated with higher bone mineral density. Also, recent data suggest a favorable bone microarchitecture profile in these patients. However, the increase in bone mineral density does not necessarily confer protection against fractures, and the risk of fractures may vary depending on the skeletal sites.
Factors affecting bone health
Various factors, including mechanical factors, hormones, cytokines, inflammation, and bone marrow adiposity, contribute to the adverse effect of obesity on bone. The article explores these factors alongside non-invasive techniques and tools like the Fracture Risk Assessment (FRAX) to evaluate fracture risk.
Bone and Adipose tissue
This article also highlights the essential roles of hormones such as vitamin D, Parathormone (PTH), FGF-23 (Fibroblast Growth Factor 23), which affect bone health, and some of the hormones secreted from the adipose tissues such as adiponectin and leptin.
Obesity Paradox and Sarcopenic Obesity
The article delves into the intriguing obesity paradox, where an increased BMI correlates with higher bone mineral density but not necessarily reduced fracture risk. Sarcopenic obesity, a combination of excessive fat accumulation and reduced muscle mass, further complicates the relationship between obesity and bone health.
Conclusions
Physicians should keep a comprehensive approach to treating obese patients with osteoporosis, including lifestyle modifications, weight management, fall prevention strategies, and pharmacological interventions. Further research is needed to better understand the relationship between obesity and bone health.
Similar content being viewed by others
References
(2000). Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. Vol. 894, pp. i–xii, 1–253.
Conde, J., Scotece, M., Gómez, R., Lopez, V., Gómez-Reino, J. J., & Gualillo, O. (2011). Adipokines and osteoarthritis: Novel molecules involved in the pathogenesis and progression of disease. Arthritis, 2011, 203901.
Astudillo, P., Ríos, S., Pastenes, L., Pino, A. M., & Rodríguez, J. P. (2008). Increased adipogenesis of osteoporotic human-mesenchymal stem cells (MSCs) characterizes by impaired leptin action. Journal of Cellular Biochemistry, 103(4), 1054–1065.
Gordeladze, J. O., Drevon, C. A., Syversen, U., & Reseland, J. E. (2002). Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. Journal of Cellular Biochemistry, 85(4), 825–836.
Reid, I. R., Baldock, P. A., & Cornish, J. (2018). Effects of leptin on the skeleton. Endocrine Reviews, 39(6), 938–959.
Tu, Q., Zhang, J., Dong, L. Q., Saunders, E., Luo, E., Tang, J., & Chen, J. (2011). Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. Journal of Biological Chemistry, 286(14), 12542–12553.
Lee, H. W., Kim, S. Y., Kim, A. Y., Lee, E. J., Choi, J. Y., & Kim, J. B. (2009). Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells., 27(9), 2254–2262.
Gkastaris, K., Goulis, D. G., Potoupnis, M., Anastasilakis, A. D., & Kapetanos, G. (2020). Obesity, osteoporosis and bone metabolism. Journal of Musculoskeletal and Neuronal Interactions, 2(3), 372–381.
Gao, B., Huang, Q., Lin, Y. S., Wei, B. Y., Guo, Y. S., Sun, Z., Wang, L., Fan, J., Zhang, H. Y., Han, Y. H., Li, X. J., Shi, J., Liu, J., Yang, L., & Luo, Z. J. (2014). Dose-dependent effect of estrogen suppresses the osteo-adipogenic transdifferentiation of osteoblasts via canonical Wnt signaling pathway. PLoS ONE, 9(6), e99137.
Zhao, L. J., Jiang, H., Papasian, C. J., Maulik, D., Drees, B., Hamilton, J., & Deng, H. W. (2008). Correlation of obesity and osteoporosis: Effect of fat mass on the determination of osteoporosis. Journal of Bone and Mineral Research, 23(1), 17–29.
Tang, X., Liu, G., Kang, J., Hou, Y., Jiang, F., Yuan, W., & Shi, J. (2013). Obesity and risk of hip fracture in adults: A meta-analysis of prospective cohort studies. PLoS ONE, 8(4), e55077.
Santora, L., & Skolbekken, J.-A. (2011). From brittle bones to standard deviations: The historical development of osteoporosis in the late twentieth century. Science, Technology, & Human Values, 36(4), 497–521.
Addison, O., Marcus, R. L., Lastayo, P. C., & Ryan, A. S. (2014). Intermuscular fat: A review of the consequences and causes. International Journal of Endocrinology, 2014, 309570.
Leeners, B., Geary, N., Tobler, P. N., & Asarian, L. (2017). Ovarian hormones and obesity. Human Reproduction Update, 23(3), 300–321.
Philbrick, K. A., Wong, C. P., Branscum, A. J., Turner, R. T., & Iwaniec, U. T. (2017). Leptin stimulates bone formation in ob/ob mice at doses having minimal impact on energy metabolism. Journal of Endocrinology, 232(3), 461–474.
Ruhl, C. E., & Everhart, J. E. (2002). Relationship of serum leptin concentration with bone mineral density in the United States population. Journal of Bone and Mineral Research, 17(10), 1896–1903.
Pasco, J. A., Henry, M. J., Kotowicz, M. A., Collier, G. R., Ball, M. J., Ugoni, A. M., & Nicholson, G. C. (2001). Serum leptin levels are associated with bone mass in nonobese women. Journal of Clinical Endocrinology and Metabolism, 86(5), 1884–1887.
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000). Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell, 100(2), 197–207.
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., … Kadowaki, T. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 7(8), 941–946.
Savvidis, C., Tournis, S., & Dede, A. D. (2018). Obesity and bone metabolism. Hormones (Athens, Greece), 17(2), 205–217.
Thommesen, L., Stunes, A. K., Monjo, M., Grøsvik, K., Tamburstuen, M. V., Kjøbli, E., Lyngstadaas, S. P., Reseland, J. E., & Syversen, U. (2006). Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. Journal of Cellular Biochemistry, 99(3), 824–834.
Ionova-Martin, S. S., Do, S. H., Barth, H. D., Szadkowska, M., Porter, A. E., Ager, J. W., 3rd., Ager, J. W., Jr., Alliston, T., Vaisse, C., & Ritchie, R. O. (2010). Reduced size-independent mechanical properties of cortical bone in high-fat diet-induced obesity. Bone, 46(1), 217–225.
Halade, G. V., El Jamali, A., Williams, P. J., Fajardo, R. J., & Fernandes, G. (2011). Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Experimental Gerontology, 46(1), 43–52.
Menagh, P. J., Turner, R. T., Jump, D. B., Wong, C. P., Lowry, M. B., Yakar, S., Rosen, C. J., & Iwaniec, U. T. (2010). Growth hormone regulates the balance between bone formation and bone marrow adiposity. Journal of Bone and Mineral Research, 25(4), 757–768.
Sekiya, I., Larson, B. L., Vuoristo, J. T., Cui, J. G., & Prockop, D. J. (2004). Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). Journal of Bone and Mineral Research, 19(2), 256–264.
Guo, Y. F., Xiong, D. H., Shen, H., Zhao, L. J., Xiao, P., Guo, Y., Wang, W., Yang, T. L., Recker, R. R., & Deng, H. W. (2006). Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. Journal of Medical Genetics, 43(10), 798–803.
Kajkenova, O., Lecka-Czernik, B., Gubrij, I., Hauser, S. P., Takahashi, K., Parfitt, A. M., Jilka, R. L., Manolagas, S. C., & Lipschitz, D. A. (1997). Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. Journal of Bone and Mineral Research, 12(11), 1772–1779.
Duque, G., Macoritto, M., & Kremer, R. (2004). Vitamin D treatment of senescence accelerated mice (SAM-P/6) induces several regulators of stromal cell plasticity. Biogerontology, 5(6), 421–429.
Walsh, J. S., Evans, A. L., Bowles, S., Naylor, K. E., Jones, K. S., Schoenmakers, I., Jacques, R. M., & Eastell, R. (2016). Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health. American Journal of Clinical Nutrition, 103(6), 1465–1471.
Ardawi, M. S., Qari, M. H., Rouzi, A. A., Maimani, A. A., & Raddadi, R. M. (2011). Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporosis International, 22(2), 463–475.
Grace, C., Vincent, R., & Aylwin, S. J. (2014). High prevalence of vitamin D insufficiency in a United Kingdom urban morbidly obese population: Implications for testing and treatment. Surgery for Obesity and Related Diseases, 10(2), 355–360.
Snijder, M. B., van Dam, R. M., Visser, M., Deeg, D. J., Dekker, J. M., Bouter, L. M., Seidell, J. C., & Lips, P. (2005). Adiposity in relation to vitamin D status and parathyroid hormone levels: A population-based study in older men and women. Journal of Clinical Endocrinology and Metabolism, 90(7), 4119–4123.
Tomlinson, J. W., Bujalska, I., Stewart, P. M., & Cooper, M. S. (2000). The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis. Endocrine Research, 26(4), 711–722.
Cooper, M. S., Bujalska, I., Rabbitt, E., Walker, E. A., Bland, R., Sheppard, M. C., Hewison, M., & Stewart, P. M. (2001). Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: An autocrine switch from glucocorticoid inactivation to activation. Journal of Bone and Mineral Research, 16(6), 1037–1044.
Mitchell, R. J., Lord, S. R., Harvey, L. A., & Close, J. C. (2015). Obesity and falls in older people: Mediating effects of disease, sedentary behavior, mood, pain and medication use. Archives of Gerontology and Geriatrics, 60(1), 52–58.
Bauer, J. M., Cruz-Jentoft, A. J., Fielding, R. A., Kanis, J. A., Reginster, J. Y., Bruyère, O., Cesari, M., Chapurlat, R., Al-Daghri, N., Dennison, E., Kaufman, J. M., Landi, F., Laslop, A., Locquet, M., Maggi, S., McCloskey, E., Perna, S., Rizzoli, R., Rolland, Y., … Cooper, C. (2019). Is there enough evidence for osteosarcopenic obesity as a distinct entity? A critical literature review. Calcified Tissue International, 105(2), 109–124.
Premaor, M. O., Comim, F. V., & Compston, J. E. (2014). Obesity and fractures. Arquivos Brasileiros de Endocrinologia e Metabologia, 58(5), 470–477.
Compston, J. (2015). Obesity and fractures in postmenopausal women. Current Opinion in Rheumatology, 27(4), 414–419.
Compston, J. E., Watts, N. B., Chapurlat, R., Cooper, C., Boonen, S., Greenspan, S., Pfeilschifter, J., Silverman, S., Díez-Pérez, A., Lindsay, R., Saag, K. G., Netelenbos, J. C., Gehlbach, S., Hooven, F. H., Flahive, J., Adachi, J. D., Rossini, M., Lacroix, A. Z., Roux, C., … Glow Investigators. (2011). Obesity is not protective against fracture in postmenopausal women: GLOW. The American Journal of Medicine, 124(11), 1043–1050.
Premaor, M. O., Pilbrow, L., Tonkin, C., Parker, R. A., & Compston, J. (2010). Obesity and fractures in postmenopausal women. Journal of Bone and Mineral Research, 25(2), 292–297.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard statement
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Arjunan, D., Prasad, T.N., Das, L. et al. Osteoporosis and Obesity. JOIO 57 (Suppl 1), 218–224 (2023). https://doi.org/10.1007/s43465-023-01052-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43465-023-01052-9